Virpax Pharmaceuticals is a preclinical stage biopharmaceutical company focused on becoming an pain management by developing and delivering non-opioid and non-addictive pharmaceutical products using new drug delivery systems and technology. Co. is developing branded pharmaceutical product candidates for pain management by using advanced technology in an effort to enhance patients' quality of life. The VRPX stock yearly return is shown above.
The yearly return on the VRPX stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2023 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the VRPX annual return calculation with any dividends reinvested as applicable (on ex-dates).
|